Zentalis Pharmaceuticals Llc (ZNTL) — Financial Flexibility Index
Zentalis Pharmaceuticals Llc (ZNTL) has a Financial Flexibility Index of -0.43x as of December 2025. Free cash flow of $-30.94 Million (operating CF $-30.94 Million minus capex $0.00) represents 0% of total liabilities ($72.76 Million). Check Zentalis Pharmaceuticals Llc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zentalis Pharmaceuticals Llc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Zentalis Pharmaceuticals Llc across 8 annual periods. For the full cash flow conversion analysis, see Zentalis Pharmaceuticals Llc (ZNTL) cash flow conversion.
Annual Financial Flexibility Index for Zentalis Pharmaceuticals Llc (2018–2025)
Year-by-year free cash flow to debt coverage for Zentalis Pharmaceuticals Llc. Explore Zentalis Pharmaceuticals Llc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.72x | $-125.25 Million | $-125.25 Million | $72.76 Million | ▲ +6.0% |
| 2024 | -1.83x | $-170.64 Million | $-170.86 Million | $93.15 Million | ▼ -10.2% |
| 2023 | -1.66x | $-207.24 Million | $-207.82 Million | $124.64 Million | ▼ -23.2% |
| 2022 | -1.35x | $-161.20 Million | $-163.75 Million | $119.43 Million | ▲ +1.9% |
| 2021 | -1.38x | $-147.99 Million | $-154.09 Million | $107.54 Million | ▲ +48.6% |
| 2020 | -2.67x | $-86.07 Million | $-86.83 Million | $32.18 Million | ▼ -36.6% |
| 2019 | -1.96x | $-38.79 Million | $-39.14 Million | $19.81 Million | ▲ +29.2% |
| 2018 | -2.76x | $-24.02 Million | $-24.25 Million | $8.69 Million | — |